Genomic (in)stability of the breast tumor microenvironment

Molecular Cancer Research

Volumn 10, Issue 12, 2012, Pages 1526-1531

  Rummel, Seth ^a   Valente, Allyson L ^a   Kane, Jennifer L ^a   Shriver, Craig D ^c   Ellsworth, Rachel E ^b  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FORMALDEHYDE;

ADULT; ALLELIC IMBALANCE; ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; CANCER ADJUVANT THERAPY; COPY NUMBER VARIATION; DISEASE COURSE; FEMALE; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE; TISSUE PRESERVATION; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; BREAST NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84871399056     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0425     Document Type: Article

References (25)

1. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-5. (Pubitemid 36519405)
2. Chiquet-Ehrissmann R,Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9. (Pubitemid 17181535)
3. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracine function. Cancer Res 1995;55:2448-54.
4. Yee D, Rosen N, Favoni RE, Cullen KJ. The insulin-like growth factors and their receptors, and their binding proteins in human breast cancer. Cancer Treat Res 1991;53:93-106.
5. Boudreau N, Myers C. Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res 2003;5:140-6. (Pubitemid 36519407)
6. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-9. (Pubitemid 27020695)
7. Moinfar F, Man YG, Arnold L, Bratthauer GL, Ratschchek M, Tavassoli FA. Concurrent and independent genetic alterations in stromal and epithelial cells ofmammary carcinoma: implications for tumorigenesis. Cancer Res 2000;60:2562-6. (Pubitemid 30262453)
8. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 2004;64:7231-6. (Pubitemid 39372057)
9. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, et al. Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol 2004;11:861-8.
10. Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD. Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol 2004;5:753-8. (Pubitemid 39646786)
11. Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 2006;78:961-72. (Pubitemid 43787688)
12. Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007;297:2103-11. (Pubitemid 46798168)
13. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32. (Pubitemid 38903159)
14. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005;37:899-905. (Pubitemid 41077119)
15. Hu M, Polyak K. Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 2008;44:2760-5.
16. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al. No evidence of clonal somatic genetic alterations in cancer-associated fi broblasts from human breast and ovarian carcinomas. Nat Genet 2008;40:650-5. (Pubitemid 351601206)
17. Holliday C, Rummel S, Hooke JA, Shriver CD, Ellsworth DL, Ellsworth RE. Genomic instability in the breast microenvironment? A critical evaluation of the evidence. Expert Rev Mol Diagn 2009;9:667-78.
18. Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009;25:30-8.
19. Campbell I, Qiu W, Haviv I. Genetic changes in tumor microenvironments. J Pathol 2011;223:450-8.
20. Oudin C, Bonnetain F, Boidot R, Vegran F, Soubeyrand M-S, Arnould L, et al. Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy. Int J Oncol 2007;30:1145-51.
21. Li Z, Moore DH, Meng ZH, Ljung B-M, Gray JW, Dairkee SH. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res 2002;62:1000-3. (Pubitemid 34160277)
22. Ellsworth RE, Ellsworth DL, Lubert SM, Hooke J, Somiari RI, Shriver CD. High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:915-9. (Pubitemid 37151529)
23. Medintz IL, Lee C-CR, Wong WW, Pirkola K, Sidransky D, Mathies RA. Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res 2000;10:1211-8.
24. Farrand K, Jovanovic L, Delahunt D, McIver B, Hay ID, Eberhardt NL, et al. Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn 2002;4:150-8.
25. Williams C, Ponten F, Moberg C, Soderkvist P, Uhlen M, Ponten J, et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 1999;155:1467-71.